InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Discover the detailed record of transactions filed by ADAMS R MARK, Chief Operating Officer. Insider active across 1 companies, notably Adaptive Biotechnologies Corp. In total, 12 filings have been recorded. Total volume traded: €755k. The latest transaction was filed on 7 April 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
€10,073831 shares@ €12.12170.0005% mcap0.7% of flow
Common Stock
SEC:0001209191-22-023916:0·
074,135 shares0
Common Stock
SEC:0001209191-22-017392:0·
€21,0761,021 shares@ €20.64290.0010% mcap2.9% of flow
Common Stock
SEC:0001209191-22-002766·
€21,0761,021 shares@ €20.64290.0010% mcap1.5% of flow
Common Stock
SEC:0001209191-22-002766:0·
€37,1901,324 shares@ €28.08880.0018% mcap5.2% of flow
Common Stock
SEC:0001209191-21-060116·
€37,1901,324 shares@ €28.08880.0018% mcap2.6% of flow
Common Stock
SEC:0001209191-21-060116:0·
€29,114871 shares@ €33.42550.0014% mcap4.1% of flow
Common Stock
SEC:0001209191-21-046083·
€29,114871 shares@ €33.42550.0014% mcap2.0% of flow
Common Stock
SEC:0001209191-21-046083:0·
€343,96714,583 shares@ €23.58690.017% mcap48.0% of flow
Common Stock
SEC:0001209191-21-042290·
€343,96714,583 shares@ €23.58690.017% mcap23.8% of flow
Common Stock
SEC:0001209191-21-042290:0·
€285,0928,914 shares@ €31.98250.014% mcap39.8% of flow
Common Stock
SEC:0001209191-21-041088·
€285,0928,914 shares@ €31.98250.014% mcap19.8% of flow
Common Stock
SEC:0001209191-21-041088:0·
12 of 12 declarations
About ADAMS R MARK
R. Mark Adams is the Chief Operating Officer at Adaptive Biotechnologies Corp. He oversees the daily operations of the company and ensures that processes are optimized to meet strategic objectives. Adams plays a key role in implementing operational strategies and continuously improving performance.
